Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study

FLU-v, developed by PepTcell (SEEK), is a peptide vaccine aiming to provide a broadly protective cellular immune response against influenza A and B. A randomized, double-blind, placebo-controlled, single-center, phase IIb efficacy and safety trial was conducted. One hundred and fifty-three healthy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleguezuelos, Olga, James, Emma, Fernandez, Ana, Lopes, Victor, Rosas, Luz Angela, Cervantes-Medina, Adriana, Cleath, Jason, Edwards, Kristina, Neitzey, Dana, Gu, Wenjuan, Hunsberger, Sally, Taubenberger, Jeffery K., Stoloff, Gregory, Memoli, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069936/
https://www.ncbi.nlm.nih.gov/pubmed/32194999
http://dx.doi.org/10.1038/s41541-020-0174-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069936/
https://www.ncbi.nlm.nih.gov/pubmed/32194999
http://dx.doi.org/10.1038/s41541-020-0174-9

Ejemplares similares